Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis

Fig. 3

Forest plot for all patients: composite clinical response. ASAC ampicillin/sulbactam or amoxicillin/clavulanate, CEF ceftaroline, CEFT ceftobiprole, DAL dalbavancin, DAP daptomycin, DEL delafloxacin, FUS fusidic acid, ICL iclaprim, LIN linezolid, OD oxacillin + dicloxacillin, OMA omadacycline, ST standard therapy, TED tedizolid, TEL telavancin, TIG tigecycline, VA vancomycin + aztreonam, VAN vancomycin, VL vancomycin + linezolid

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us